Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients.
Pharmaceutics. 2023 Jan 3;15(1):163. doi: 10.3390/pharmaceutics15010163.
Pharmaceutics. 2023.
PMID: 36678792
Free PMC article.
Review.
Prescribing errors in post - COVID-19 patients: prevalence, severity, and risk factors in patients visiting a post - COVID-19 outpatient clinic.
Mahomedradja RF, van den Beukel TO, van den Bos M, Wang S, Kalverda KA, Lissenberg-Witte BI, Kuijvenhoven MA, Nossent EJ, Muller M, Sigaloff KCE, Tichelaar J, van Agtmael MA.
Mahomedradja RF, et al. Among authors: kuijvenhoven ma.
BMC Emerg Med. 2022 Mar 5;22(1):35. doi: 10.1186/s12873-022-00588-7.
BMC Emerg Med. 2022.
PMID: 35247982
Free PMC article.
Item in Clipboard
TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).
Kuijvenhoven MA, Wilhelm AJ, Meijer E, Janssen JJWM, Swart EL.
Kuijvenhoven MA, et al.
Eur J Haematol. 2021 Sep;107(3):364-369. doi: 10.1111/ejh.13674. Epub 2021 Jun 23.
Eur J Haematol. 2021.
PMID: 34114691
Item in Clipboard
The pharmacotherapy team: A novel strategy to improve appropriate in-hospital prescribing using a participatory intervention action method.
Mahomedradja RF, Sigaloff KCE, Bekema JK, Dekker MJHJ, Brinkman DJ, Kuijvenhoven MA, van Beneden MLH, Lissenberg-Witte BI, Tichelaar J, van Agtmael MA.
Mahomedradja RF, et al. Among authors: kuijvenhoven ma.
Br J Clin Pharmacol. 2021 Feb;87(2):565-576. doi: 10.1111/bcp.14418. Epub 2020 Jul 9.
Br J Clin Pharmacol. 2021.
PMID: 32520431
Free PMC article.
Item in Clipboard
Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.
Kuijvenhoven MA, Haak EA, Gombert-Handoko KB, Crul M.
Kuijvenhoven MA, et al.
Int J Clin Pharm. 2013 Dec;35(6):1099-104. doi: 10.1007/s11096-013-9830-8. Epub 2013 Aug 22.
Int J Clin Pharm. 2013.
PMID: 23974985
Item in Clipboard
Cite
Cite